 Todays massive upward move in ORPH stock appears to be the result of a disclosed stake in the company of more than 5 from Goldman Sachs. The post ORPH Stock: Why Orphazyme Is Gaining Today Despite FDA Disappointment appeared first on InvestorPlace. 